Day 1Monday, March 10, 2025 - ET (Eastern Time, GMT-05:00)

Taking your biotech company public is a game-changer—but are you truly ready? This masterclass will walk you through the essential steps, strategic decisions, and financial considerations to ensure a successful transition from private to public markets.

• Status of the US IPO Market – Transactions that are closing
• IPO Readiness Check – Key financial, operational, structural, and leadership elements you need in place.
• Valuation & Funding Needs – How to determine your worth and secure the right amount of capital.
• Why & How to Go Public – Understanding the motivations, risks, and different pathways (IPO, RTO, SPAC, direct listing).
• Avoiding Pitfalls – Common challenges biotech companies face and how to navigate them.
• IPO Process – Financial Requirements, Listing Requirements, Legal Filings

The M&A Masterclass is tailored for life sciences start-ups aiming to explore M&A opportunities and best practices with larger strategic companies. This session offers strategic insights into the M&A process, equipping emerging biotech and medtech companies with the knowledge to successfully navigate these transformative deals.

Led by experienced M&A professionals, the masterclass will cover key topics such as valuation, deal structuring, due diligence, and post-merger integration. Attendees will learn how to position their companies as attractive acquisition targets, negotiate favorable terms, and align with the strategic goals of large pharma partners.